(Q27655433)
Statements
Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity (English)
0 references
15 June 2009
0 references
19
0 references
12
0 references
3253-8
0 references